Development of a multicomponent implementation strategy to reduce upper gastrointestinal bleeding risk in patients using warfarin and antiplatelet therapy, and protocol for a pragmatic multilevel randomized factorial pilot implementation trial

BACKGROUND: The concomitant use of anticoagulant and antiplatelet medications increases the risk of upper gastrointestinal (GI) bleeding. Two underused evidence-based practices (EBPs) can reduce the risk: de-prescribe unnecessary antiplatelet therapy or initiate a proton pump inhibitor. We describe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurlander, Jacob E., Helminski, Danielle, Lanham, Michael, Henstock, Jennifer L., Kidwell, Kelley M., Krein, Sarah L., Saini, Sameer D., Richardson, Caroline R., De Vries, Raymond, Resnicow, Kenneth, Ruff, Allison Laboon, Wallace, David M., Jones, Elizabeth K., Perry, Linda K., Parsons, Jacqueline, Ha, Nghi, Alexandris-Souphis, Tina, Dedrick, Dale, Aldridge, Elizabeth, Barnes, Geoffrey D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796614/
https://www.ncbi.nlm.nih.gov/pubmed/35090577
http://dx.doi.org/10.1186/s43058-022-00256-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796614/
https://www.ncbi.nlm.nih.gov/pubmed/35090577
http://dx.doi.org/10.1186/s43058-022-00256-8

Ejemplares similares